wire - news in brief


Category



Results 101 - 150 of 426.


Environment - Life Sciences - 17.06.2021
Protection and promotion of native crayfish
Protection and promotion of native crayfish
Formerly widespread, native crayfish in Switzerland are now highly endangered. With support from Eawag, experts are doing everything they can to preserve the secretive river dwellers.

Health - Pharmacology - 16.06.2021
How do immune cells get activated?
How do immune cells get activated?
By studying the structure of cellular receptors and of the molecules that activate them, scientists at the Universities of Geneva and Basel are deciphering the details of immune cell activation. Chemokine receptors, located at the surface of many immune cells, play an important role in their function.

Pharmacology - Health - 16.06.2021

Agronomy / Food Science - Environment - 16.06.2021
Updating the self-sufficiency ratio
Updating the self-sufficiency ratio
The level of self-sufficiency indicates the extent to which agricultural performance ensures food security.

Computer Science - Campus - 16.06.2021
New Imaging Center Pools the Know-How of Five EPFL Schools
New Imaging Center Pools the Know-How of Five EPFL Schools
EPFL has just opened a new imaging center to serve as a hub for state-of-the-art technology in imaging systems.

Environment - Economics / Business - 15.06.2021

Computer Science - Campus - 15.06.2021
Artificial intelligence speeds land-use classification
Artificial intelligence speeds land-use classification
An EPFL Master's student has shown that artificial intelligence can be used to further automate the process of land-use classification in Switzerland, especially for rare and complicated land categories that until now have been classified manually.

Materials Science - Physics - 14.06.2021

Astronomy / Space Science - 14.06.2021
State Secretary Hirayama in Portugal to attend Africa-Europe Space Earth Observation High-Level Forum and hold bilateral talks
State Secretary Martina Hirayama participated in the Africa-Europe Space Earth Observation High-Level Forum in Lisbon on 11 and 12 June.

Life Sciences - Chemistry - 14.06.2021
They build proteins that are not known to nature
They build proteins that are not known to nature
Using chemical synthesis, Bright Peak Therapeutics can produce proteins that have never before existed.

Event - Life Sciences - 14.06.2021

Innovation - Administration - 14.06.2021

Environment - Economics / Business - 11.06.2021
Skewed perceptions in climate policy
The benefits of strict climate policies are often underestimated in public debate, while the costs are generally overestimated, says Lucas Bretschger. Climate protection does not have a negative impact on economic development. Climate policies will permanently affect the structures of our economies.

Computer Science - Mathematics - 11.06.2021
How ETH students established the first all-female Olympiad in Informatics
How ETH students established the first all-female Olympiad in Informatics
Next week, the first European Girls' Olympiad in Informatics will take place in Zurich. The competition, which will have around 160 participants from 43 countries, is being organised by ETH students, who also came up with the original idea and are the driving force behind the event.

Pharmacology - Health - 11.06.2021
Novartis investigational oral therapy iptacopan (LNP023) shows benefit as monotherapy in treatment-na´ve patients with rare and life-threatening blood disorder paroxysmal nocturnal hemoglobinuria
First-in-class, oral, targeted factor B inhibitor iptacopan substantially reduced both intraand extravascular hemolysis when given as monotherapy in a Phase II study of anti-C5 na´ve paroxysmal noctu

Health - Pharmacology - 11.06.2021

Pharmacology - Health - 11.06.2021
Roche announces data at EHA2021 reinforcing efficacy of Venclexta/Venclyxto combinations in chronic lymphocytic leukaemia and acute myeloid leukaemia
Four-year follow-up analysis from the phase III CLL14 study showed progression-free survival rate of 74.0% in previously untreated patients with chronic lymphocytic leukaemia (CLL) three years

Environment - 11.06.2021

Pedagogy - 10.06.2021
'Mars Mission' attracts more than 700 students from around the world
’Mars Mission’ attracts more than 700 students from around the world
The R2T2 Mars Mission is an educational project developed at EPFL for grade-school and high-school classes that use the Thymio robot.

Computer Science - Campus - 10.06.2021

Innovation - Environment - 10.06.2021
NEST to open its virtual doors
The research and innovation building NEST of Empa and Eawag can now be visited virtually at any time and from anywhere in the world.

Research Management - Campus - 09.06.2021

Veterinary - 08.06.2021
No room for discrimination or harassment
Discrimination and harassment violate scientific integrity - but the damage they do goes beyond that.

Physics - Chemistry - 08.06.2021

Pharmacology - Health - 07.06.2021
Novartis announces new interim analysis Phase II data for iptacopan in rare kidney disease C3 glomerulopathy (C3G)
Data shows investigational iptacopan improved estimated glomerular filtration rate (eGFR) slope and stabilized kidney function in patients with C3G 1 ; Phase III clinical trial to start in 2021 Resul

Health - Life Sciences - 07.06.2021
Modelling lungs to limit testing on mice
Modelling lungs to limit testing on mice
The UNIGE is awarding its 3R prize to the creator of a cell model which, by reproducing a lung infection, has enabled the identification of a promising treatment.á Pseudomonas aeruginosa is a bacterium responsible for many lung infections, particularly in people with cystic fibrosis or a weakened immune system.

Environment - Architecture - 07.06.2021
EPFL architecture students explore outdoor spaces in Geneva Canton
EPFL architecture students explore outdoor spaces in Geneva Canton
Throughout the summer, architectural works by first-year students at EPFL's ALICE studio will be on display at four sites in Geneva Canton: Genthod, Aigues-Vertes, Vernier and Onex.

Pharmacology - Health - 07.06.2021
Approval for New Alzheimer’s Drug Developed at UZH
The active ingredient aducanumab, which was discovered at the University of Zurich, has been approved for use in the United States as a treatment for Alzheimer's disease.

Pharmacology - Health - 06.06.2021
Novartis announces iptacopan met Phase II study primary endpoint in rare kidney disease IgA nephropathy (IgAN)
Phase II primary endpoint results for investigational iptacopan in IgAN demonstrated effective and clinically meaningful reduc tion of proteinuria 1 - a key risk predictor in kidney disease progressi

Pharmacology - Health - 04.06.2021
Roche presents latest advances with immunotherapies in non-Hodgkin lymphoma
Data for investigational CD20xCD3 bispecific antibodies and new combination regimens with Polivy showed enhanced clinical benefits for people with non-Hodgkin lymphoma in early studies Basel, 4 June

Health - Environment - 04.06.2021
Researchers put technology to work for the global South
Researchers put technology to work for the global South
Tech4Dev, an EPFL program to develop technology that addresses the specific needs and living conditions of communities in the developing world, has announced four new winning projects for its research grants.

Environment - Social Sciences - 04.06.2021
A social network for global ecosystem restoration
A social network for global ecosystem restoration
ETH spin-off Restor aims to increase the success rate of ecosystem restoration and conservation projects by connecting people with better data and ecological transparency.

Pharmacology - Health - 04.06.2021
Novartis announces Tabrecta first published overall survival and updated overall response data in patients with METex14 metastatic NSCLC
Tabrecta (capmatinib) showed a median overall survival (OS) of 20.8 months in treatment-na´ve patients and 13.6 months in previously-treated patients in first published mature data 1,2

Economics / Business - Health - 04.06.2021

Astronomy / Space Science - 03.06.2021
Attractive locations work like large planets
Attractive locations work like large planets
Using large-scale mobility data from diverse cities around the globe, researchers from ETH Zurich, MIT and the Santa Fe Institute discover a powerful yet surprisingly simple travel law that governs the number of visitors to any location in a city.

Health - Life Sciences - 03.06.2021
Better choice of contraceptives can prevent breast cancer
Better choice of contraceptives can prevent breast cancer
There is a strong link between hormonal contraceptives and breast cancer risk. The main culprit are progestins, synthetic mimics of the pregnancy hormone progesterone that stimulate cell growth in the breast.

Materials Science - Environment - 03.06.2021
The biodegradable battery
The biodegradable battery
The number of data-transmitting microdevices, for instance in packaging and transport logistics, will increase sharply in the coming years.

Pharmacology - Health - 03.06.2021
Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal NETTER-1 study with targeted radioligand therapy Lutathera
At final analysis, study showed clinically relevant improvement in median overall survival with a difference of 11.7 months between arms (Hazard ratio (HR): 0.84 with 95% CI: (0.

Economics / Business - 02.06.2021
Implications of 'short squeezes' on financial market efficiency
Implications of ’short squeezes’ on financial market efficiency
Financial markets are often subject to sudden asset price surges and dips, most of the time due to the classic market dynamics of mismatched supply and demand.

Pharmacology - Health - 02.06.2021
Novartis Kisqali reports longest median overall survival in postmenopausal HR+/HER2- metastatic breast cancer patients
MONALEESA-3 median overall survival (OS) results of 53.7 months underscore that Kisqali offers more life to postmenopausal women with HR+/HER2- metastatic breast cancer (MBC) in addition to th

Health - Pharmacology - 01.06.2021
The simulated patient
The simulated patient
Digital twins enable customized medical therapies. researchers have now modeled several hundred such avatars based on real people and treated them experimentally.